Network abnormalities and interneuron dysfunction in Alzheimer disease (Q38796950)

6 September 2017

1 reference

title

Network abnormalities and interneuron dysfunction in Alzheimer disease (English)

1 reference

6 September 2017

0 references

2

Lennart Mucke

1 reference

6 September 2017

Jorge J Palop

1

1 reference

PubMed ID

27829687

6 September 2017

language of work or name

English

0 references

publication date

10 November 2016

1 reference

Nature Reviews Neuroscience

6 September 2017

1 reference

6 September 2017

17

1 reference

6 September 2017

12

1 reference

6 September 2017

777-792

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn.2016.141

6 September 2017

0 references

cites work

Medial temporal lobe default mode functioning and hippocampal structure as vulnerability indicators for schizophrenia: a MRI study of non-psychotic adolescent first-degree relatives

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Epileptic discharges affect the default mode network--FMRI and intracerebral EEG evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Default mode network alterations during language task performance in children with benign epilepsy with centrotemporal spikes (BECTS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid deposition is associated with impaired default network function in older persons without dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The role of default network deactivation in cognition and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

CORTICAL EXCITATORY STATE AND VARIABILITY IN HUMAN BRAIN RHYTHMS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Internal brain state regulates membrane potential synchrony in barrel cortex of behaving mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Thalamic control of cortical states.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Alzheimer's disease genetics: from the bench to the clinic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Intramembrane proteolysis by presenilins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Three dimensions of the amyloid hypothesis: time, space and 'wingmen'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Probing the biology of Alzheimer's disease in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

31 March 2020

The many faces of tau

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Alzheimer mechanisms and therapeutic strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Immune attack: the role of inflammation in Alzheimer disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Tau suppression in a neurodegenerative mouse model improves memory function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Biochemistry and cell biology of tau protein in neurofibrillary degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Apolipoprotein e sets the stage: response to injury triggers neuropathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Age, neuropathology, and dementia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Brain amyloid-β oligomers in ageing and Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A beta oligomers - a decade of discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A specific amyloid-beta protein assembly in the brain impairs memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuroinflammation in Alzheimer's disease: from pathogenesis to a therapeutic target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Oxygen Level and LFP in Task-Positive and Task-Negative Areas: Bridging BOLD fMRI and Electrophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Antagonistic neural networks underlying differentiated leadership roles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A default mode of brain function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Functional connectivity in the resting brain: a network analysis of the default mode hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Functional alterations in memory networks in early Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Patterns of brain activation in people at risk for Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Reduced grid-cell-like representations in adults at genetic risk for Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Altered deactivation in individuals with genetic risk for Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Medial temporal lobe function and structure in mild cognitive impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

DNA damage and its links to neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The role of apolipoprotein E in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Single App knock-in mouse models of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Sleep drives metabolite clearance from the adult brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuronal activity regulates the regional vulnerability to amyloid-β deposition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

APP processing and synaptic function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Basal GABA regulates GABA(B)R conformation and release probability at single hippocampal synapses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

η-Secretase processing of APP inhibits neuronal activity in the hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid-β-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Early onset of hypersynchronous network activity and expression of a marker of chronic seizures in the Tg2576 mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuronal structure is altered by amyloid plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hyperexcitability and epileptic seizures in a model of frontotemporal dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Tau reduction prevents Abeta-induced defects in axonal transport.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Antisense reduction of tau in adult mice protects against seizures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Advanced Alzheimer's disease is a risk factor for late-onset seizures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Seizures and myoclonus in patients with Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Incidence of new-onset seizures in mild to moderate Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Epileptic Seizures in Alzheimer Disease: A Review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Incidence and predictors of seizures in patients with Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Seizures and dementia in the elderly: Nationwide Inpatient Sample 1999-2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Seizures and epileptiform activity in the early stages of Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Dementia and adult-onset unprovoked seizures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Epilepsy and cognitive impairments in Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Phenotype associated with APP duplication in five families.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Seizures in dominantly inherited Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A prospective study of Alzheimer disease in Down syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Cross-frequency coupling between neuronal oscillations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Network state-dependent inhibition of identified hippocampal CA3 axo-axonic cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neural synchrony in cortical networks: history, concept and current status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Network oscillations modulate interictal epileptiform spike rate during human memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Gamma oscillations distinguish true from false memories

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hippocampal and neocortical gamma oscillations predict memory formation in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Human gamma-frequency oscillations associated with attention and memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Successful execution of working memory linked to synchronized high-frequency gamma oscillations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Stimulus specificity of phase-locked and non-phase-locked 40 Hz visual responses in human

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The many faces of the gamma band response to complex visual stimuli.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Cortical state and attention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Functional mapping of human sensorimotor cortex with electrocorticographic spectral analysis. II. Event-related synchronization in the gamma band.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Synchronous and asynchronous theta and gamma activity during episodic memory formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Human EEG gamma oscillations in neuropsychiatric disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hemodynamic signals correlate tightly with synchronized gamma oscillations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neurophysiological investigation of the basis of the fMRI signal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Simultaneous EEG and fMRI of the alpha rhythm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Trial-by-trial coupling between EEG and BOLD identifies networks related to alpha and theta EEG power increases during working memory maintenance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Transient suppression of broadband gamma power in the default-mode network is correlated with task complexity and subject performance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Shift in interictal relative gamma power as a novel biomarker for drug response in two mouse models of absence epilepsy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Social network, cognitive function, and dementia incidence among elderly women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuronal oscillations in cortical networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Electrical synapses define networks of neocortical GABAergic neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Behavior-dependent specialization of identified hippocampal interneurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A cortical circuit for gain control by behavioral state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Interneuron cell types are fit to function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Interneurons from embryonic development to cell-based therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with Aβ accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

31 March 2020

Perisomatic inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Modulation of behavioral networks by selective interneuronal inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Distinct behavioural and network correlates of two interneuron types in prefrontal cortex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Driving fast-spiking cells induces gamma rhythm and controls sensory responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Increased cortical and thalamic excitability in freely moving APPswe/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Rapid and continuous modulation of hippocampal network state during exploration of new places

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Rescue of long-range circuit dysfunction in Alzheimer's disease models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

40-Hz steady state response in Alzheimer's disease and mild cognitive impairment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Increased EEG gamma band activity in Alzheimer's disease and mild cognitive impairment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuronal Network Oscillations in Neurodegenerative Diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid beta 1-42 inhibits entorhinal cortex activity in the beta-gamma range: role of GSK-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Decreased rhythmic GABAergic septal activity and memory-associated theta oscillations after hippocampal amyloid-beta pathology in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Theta-gamma coupling increases during the learning of item-context associations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Entrainment of neuronal oscillations as a mechanism of attentional selection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

High gamma power is phase-locked to theta oscillations in human neocortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Entrainment of neocortical neurons and gamma oscillations by the hippocampal theta rhythm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Interneuron Diversity series: Rhythm and mood in perisomatic inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Cross-frequency phase-phase coupling between θ and γ oscillations in the hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hilar GABAergic interneuron activity controls spatial learning and memory retrieval

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

BACE1 regulates voltage-gated sodium channels and neuronal activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Collagen VI protects neurons against Abeta toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Therapeutic potential of Na(V)1.1 activators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

A second family with familial AD and the V717L APP mutation has a later age at onset.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Phenotypical difference of amyloid precursor protein (APP) V717L mutation in Japanese family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-->glycine).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

An African American family with early-onset Alzheimer disease and an APP (T714I) mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Early onset Alzheimer's disease in a South American pedigree from Argentina.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Incidence and impact of subclinical epileptiform activity in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.141

Familial Alzheimer disease: a large, multigeneration German kindred.

31 March 2020

1 reference

12 December 2020

Myoclonus, seizures, and paratonia in Alzheimer disease

1 reference

12 December 2020

Seizures in Alzheimer disease: who, when, and how common?

1 reference

12 December 2020

Functional changes in glutamate transporters and astrocyte biophysical properties in a rodent model of focal cortical dysplasia

1 reference

12 December 2020

Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology

1 reference

12 December 2020

Spatiotemporal analysis of local field potentials and unit discharges in cat cerebral cortex during natural wake and sleep states.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRN.2016.141

1 reference

PubMed ID

27829687

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

27829687